Roche agrees to pay $21m to settle Enzo infringement suit
Swiss pharmaceutical company Roche Diagnostics has agreed to pay $21 million as part of a settlement to a patent infringement case with New York-based Enzo Biochem.
Pharma group asks USTR to drop India from watch list
The lobby group for India’s pharma industry has asked the US Trade Representative office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.
Clarivate announces new Life Science Alliances programme
Global information company Clarivate Analytics has launched a “Life Science Alliances Program” to provide drug and medical device developers a new way to advance their research and development.
UK could lose out on Europe-wide drug safety system post-Brexit
UK patients could be more exposed to counterfeit medicines than EU patients in the event of a ‘no deal’ Brexit, because access to an initiative aimed at protecting patients from fake drugs could be lost.
Dutch company’s patent for Ethiopian grain annulled
A long running dispute between two Dutch companies over ownership of methods for the processing of teff, a grain cultivated in Ethiopia, has been settled in the Court of The Hague.
University of California to be granted CRISPR patent
The University of California will soon be granted a patent related to the gene-editing technology CRISPR, according to a notice of allowance by the US Patent and Trademark Office.
Fed Circuit dismisses Momenta appeal in BMS suit
The US Court of Appeals for the Federal Circuit yesterday dismissed an appeal by Massachusetts-based biotech Momenta Pharmaceuticals in a case involving a rheumatoid arthritis drug.
Victory for Mayo in neurological disorder patent dispute
In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid.
EU court rules on Swedish medical devices TM dispute
The EU General Court today upheld the decision to invalidate a trademark owned by Swemac Innovation, a Swedish medical devices company.
Jury orders Takeda subsidiary to pay Bayer $155 million
A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
